eed to re-test - and all at no extra cost."
Paul Eros, Director of Molecular Diagnostics at Roche said: "HPV testing provides earlier identification of those women at risk of developing cervical cancer. The agreement that we have struck with Unilabs-IHS for cervical screening with the cobas HPV test, is a significant step forward towards spreading access to HPV testing at the primary screening stage. Given the clear benefits of this technology to patients as well as the NHS, we look forward to seeing the technology's timely introduction at the primary screening stage, across the country via the national cervical screening programme - promising a better deal for women and a more efficient approach to cervical screening."
About the cobas® HPV Test on the cobas 4800 platform
Roche's cobas HPV Test simultaneously detects 12 high-risk HPV types (HPV types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) as a pooled result, as well as HPV genotypes 16 and 18 individually. Roche received FDA approval on the cobas®
HPV Test and in April 2011 and launched the cobas HPV Test in countries that accept CE Mark in 2009.
Due to key features such as the "load and go" facility for reagents, The cobas HPV test is easy and simple to use with minimal hands-on and maximum walkaway time whilst providing high throughput capabilities and has the flexibility to meet smaller throughput requirements.
About Human Papillomavirus and Cervical Cancer
Persistent infection with human papillomavirus is the cause of cervical cancer in women, with HPV being found in 99.7 per cent of cervical cancers worldwide. Of the more than 118 different types of HPV, the cobas®
HPV Test identifies the 14 high-risk types associated with the development of cervical cancer and its precursor lesions. HPV types 16 and 18 have been identified as the highest risk genotypes, detected in apPage: 1 2 3 Related biology technology :1
. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture2
. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services3
. LABS, Inc. Earns AABB Accreditation for Donor Testing4
. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer5
. VetNostic Laboratories® Announces New Testing for Dog Breeds6
. US Microbiology Testing Market7
. HABIT Study Highlights Home BNP Testing May Allow for Earlier Interventions and Better Management of Heart Failure Patient8
. New White Paper Examines Clinical Trial Material Production & Testing: What Your Contract Manufacturing Organization is Not Telling You9
. Global Genetic Testing Market Analysis10
. Global Microbiology Testing Market: Facilities, Test Volumes, and Sales Forecasts by Country11
. Cell-based alternative to animal testing